Péter Ágoston

589 total citations
29 papers, 444 citations indexed

About

Péter Ágoston is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Péter Ágoston has authored 29 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiation, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Péter Ágoston's work include Advanced Radiotherapy Techniques (19 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Péter Ágoston is often cited by papers focused on Advanced Radiotherapy Techniques (19 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Péter Ágoston collaborates with scholars based in Hungary, France and United States. Péter Ágoston's co-authors include Csaba Polgár, Tibor Major, János Fodor, Zoltán Takácsi‐Nagy, Miklós Kásler, A. Somogyi, György Németh, Georgina Fröhlich, Zoltán Sulyok and Zsolt Orosz and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Péter Ágoston

28 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Ágoston Hungary 9 197 187 135 109 103 29 444
Nam Kwon Lee South Korea 11 77 0.4× 167 0.9× 143 1.1× 93 0.9× 72 0.7× 34 396
Jiro Kawamori Japan 13 97 0.5× 109 0.6× 97 0.7× 93 0.9× 114 1.1× 50 369
Mitsuhiro Takahashi Japan 12 115 0.6× 54 0.3× 138 1.0× 175 1.6× 94 0.9× 36 441
Sea-Won Lee South Korea 13 87 0.4× 77 0.4× 129 1.0× 150 1.4× 106 1.0× 37 423
Sheema Chawla United States 8 76 0.4× 58 0.3× 157 1.2× 84 0.8× 49 0.5× 15 282
Pervin Hürmüz Türkiye 12 89 0.5× 53 0.3× 89 0.7× 239 2.2× 109 1.1× 55 381
Taifu Liu China 9 44 0.2× 55 0.3× 154 1.1× 99 0.9× 24 0.2× 17 300
Douglas A. Murrey United States 9 82 0.4× 42 0.2× 100 0.7× 130 1.2× 199 1.9× 21 408
Matthew W. Jackson United States 9 28 0.1× 77 0.4× 97 0.7× 95 0.9× 21 0.2× 30 325
Tommy Sheu United States 10 58 0.3× 34 0.2× 64 0.5× 194 1.8× 75 0.7× 23 418

Countries citing papers authored by Péter Ágoston

Since Specialization
Citations

This map shows the geographic impact of Péter Ágoston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Ágoston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Ágoston more than expected).

Fields of papers citing papers by Péter Ágoston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Ágoston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Ágoston. The network helps show where Péter Ágoston may publish in the future.

Co-authorship network of co-authors of Péter Ágoston

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Ágoston. A scholar is included among the top collaborators of Péter Ágoston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Ágoston. Péter Ágoston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ágoston, Péter, et al.. (2024). Combined biological effects of CBCT and therapeutic X-ray dose on chromosomal aberrations of lymphocytes. Radiation Oncology. 19(1). 109–109. 1 indexed citations
3.
Major, Tibor, Georgina Fröhlich, Péter Ágoston, Csaba Polgár, & Zoltán Takácsi‐Nagy. (2021). The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlentherapie und Onkologie. 198(2). 93–109. 19 indexed citations
4.
Major, Tibor, et al.. (2021). Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy. Scientific Reports. 11(1). 24406–24406. 1 indexed citations
5.
Fröhlich, Georgina, et al.. (2020). Biological dose summation of intensity-modulated arc therapy and image-guided high-dose-rate interstitial brachytherapy in intermediate- and high-risk prostate cancer. Journal of Contemporary Brachytherapy. 12(3). 260–266. 1 indexed citations
6.
Fröhlich, Georgina, et al.. (2019). Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer. Strahlentherapie und Onkologie. 195(11). 991–1000. 14 indexed citations
7.
Ágoston, Péter, et al.. (2019). [Stereotactic body radiation therapy with CyberKnife accelerator for low- and intermediate risk prostate cancer].. PubMed. 63(1). 52–59. 3 indexed citations
8.
Major, Tibor, et al.. (2019). Normal tissue sparing using different techniques for prostate irradiation. Reports of Practical Oncology & Radiotherapy. 25(1). 85–90. 1 indexed citations
9.
Thariat, Juliette, Marick Laé, Sébastien Carrère, et al.. (2019). Antitumor immune response induced by NBTXR3 activated by radiotherapy.. Journal of Clinical Oncology. 37(15_suppl). e14609–e14609. 2 indexed citations
10.
Ágoston, Péter, et al.. (2017). Transperineale Implantation von Goldmarkern für die bildgestützte perkutane Strahlentherapie beim Prostatakarzinom: Eine unizentrische prospektive Studie. Strahlentherapie und Onkologie. 1–7. 5 indexed citations
11.
Ágoston, Péter, et al.. (2015). [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].. PubMed. 59(2). 148–53. 1 indexed citations
12.
Ágoston, Péter, et al.. (2012). [Patient positioning using in-room kV CT for image-guided radiotherapy (IGRT) of prostate cancer].. PubMed. 56(3). 193–8. 4 indexed citations
13.
Ágoston, Péter, et al.. (2012). Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer. Strahlentherapie und Onkologie. 188(9). 816–822. 4 indexed citations
15.
Fröhlich, Georgina, Péter Ágoston, József Lövey, Csaba Polgár, & Tibor Major. (2010). The Effect of Needle Number on the Quality of High-dose-rate Prostate Brachytherapy Implants. Pathology & Oncology Research. 16(4). 593–599. 7 indexed citations
16.
Fröhlich, Georgina, Péter Ágoston, József Lövey, et al.. (2010). Dosimetric Evaluation of High-Dose-Rate Interstitial Brachytherapy Boost Treatments for Localized Prostate Cancer. Strahlentherapie und Onkologie. 186(7). 388–395. 11 indexed citations
17.
Major, Tibor, János Fodor, Zoltán Takácsi‐Nagy, Péter Ágoston, & Csaba Polgár. (2005). Evaluation of HDR Interstitial Breast Implants Planned by Conventional and Optimized CT-Based Dosimetry Systems with Respect to Dose Homogeneity and Conformality. Strahlentherapie und Onkologie. 181(2). 89–96. 28 indexed citations
18.
Polgár, Csaba, Tibor Major, János Fodor, et al.. (2004). High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study. International Journal of Radiation Oncology*Biology*Physics. 60(4). 1173–1181. 170 indexed citations
19.
Lengyel, Zsolt, Szabolcs Szakáll, Péter Ágoston, et al.. (2002). [Cost-effective PET investigations in oncology].. PubMed. 46(3). 203–23. 1 indexed citations
20.
Szakáll, Szabolcs, Olga Ésik, Gábor Bajzik, et al.. (2002). 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.. PubMed. 43(1). 66–71. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026